Angela B Snyder (Angela Snyder)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Pediatric blood & cancer

JMIR public health and surveillance

Blood advances

Georgia State University

Yale University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Georgia State University

United States

Assistant Research Professor :: Public Management & Policy

Education History

Yale University

United States

PHD :: Public Heallth/Health Policy

Publications

Jiajing Scarlette Shi, Ankit Sutaria, Sangeetha Lakshmanan, Brandon Attell, Mei Zhou, Amy Tang, James Eckman, Angela B Snyder
Immunization adherence among children with sickle cell disease and sickle cell trait: Results of a population-based study. Pediatric blood & cancer 71 (7) (2024)
Melinda Rushing, Sophia Horiuchi, Mei Zhou, Patricia L Kavanagh, Sarah L Reeves, Angela B Snyder, Susan T Paulukonis
Emergency department 30-Day emergency department revisits among people with sickle cell disease: Variations in characteristics. Pediatric blood & cancer 71 (10) (2024)
Melinda Rushing, Sophia Horiuchi, Mei Zhou, Patricia L Kavanagh, Sarah L Reeves, Angela B Snyder, Susan T Paulukonis
Emergency department 30-Day emergency department revisits among people with sickle cell disease: Variations in characteristics. Pediatric blood & cancer (2024)
Brandon K Attell, Blake T McGee, Ann M DiGirolamo, Lindsey L Cohen, Angela B Snyder
Self-reported pain levels for emergency department visits associated with sickle cell disease in the United States. Blood advances 8 (6) (2024)
Jiajing Scarlette Shi, Ankit Sutaria, Sangeetha Lakshmanan, Brandon Attell, Mei Zhou, Amy Tang, James Eckman, Angela B Snyder
Immunization adherence among children with sickle cell disease and sickle cell trait: Results of a population-based study. Pediatric blood & cancer (2024)
Brandon K Attell, Blake T McGee, Ann M DiGirolamo, Lindsey L Cohen, Angela B Snyder
Self-reported pain levels for emergency department visits associated with sickle cell disease in the United States. Blood advances 8 (6) (2024)
Ashima Singh, Marci K Sontag, Mei Zhou, Mahua Dasgupta, Tessa L Crume, Morgan McLemore, Najibah A Galadanci, Eldrida Randall, Nicole Steiner, Amanda M Brandow, Kathryn Koch, Joshua J Field, Kathryn Hassell, Angela B Snyder, Julie Kanter
Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study. JMIR public health and surveillance 9 (2023)
Ashima Singh, Marci K Sontag, Mei Zhou, Mahua Dasgupta, Tessa L Crume, Morgan McLemore, Najibah A Galadanci, Eldrida Randall, Nicole Steiner, Amanda M Brandow, Kathryn Koch, Joshua J Field, Kathryn Hassell, Angela B Snyder, Julie Kanter
Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study. JMIR public health and surveillance 9 (2023)
Ashima Singh, Marci K Sontag, Mei Zhou, Mahua Dasgupta, Tessa L Crume, Morgan McLemore, Najibah A Galadanci, Eldrida Randall, Nicole Steiner, Amanda M Brandow, Kathryn Koch, Joshua J Field, Kathryn Hassell, Angela B Snyder, Julie Kanter
Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study. JMIR public health and surveillance 9 (2023)
Ashima Singh, Marci K Sontag, Mei Zhou, Mahua Dasgupta, Tessa L Crume, Morgan McLemore, Najibah A Galadanci, Eldrida Randall, Nicole Steiner, Amanda M Brandow, Kathryn Koch, Joshua J Field, Kathryn Hassell, Angela B Snyder, Julie Kanter
Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study. JMIR public health and surveillance 9 (2023)
Amy Tang, Jane Branscomb, Mei Zhou, Angela B Snyder, James Eckman
Characterizing complication risk from multisite, intermittent transfusions for the treatment of sickle cell disease. Pediatric blood & cancer 66 (10) (2019)

Angela B Snyder.css-eqlu8i{font-size:small;padding-left:4px;} (Angela Snyder)

Publication Activity (10 Years)

Top Topics

Top Venues

Angela B Snyder (Angela Snyder)